Conference
Readiness for Group B Streptococcus Maternal Immunisation Symposium 2026
Aarhus University and the GBS Vax-Ready European Consortium are hosting an international symposium on maternal Group B Streptococcus vaccine readiness, surveillance, evidence, and global impact.
- Host
- Aarhus University
- Abstract submission deadline
- Abstract submission deadline: May 25, 2026
- Support
- See funder guidance
- Location
- 2 to 4 September 2026, Radisson Blu Scandinavia Hotel, Aarhus, Denmark
- Discipline
- Cross-disciplinary / General
- Region
- 2 to 4 September 2026, Radisson Blu Scandinavia Hotel, Aarhus, Denmark
- Posted
- May 21, 2026
Call summary
Overview
The symposium will convene researchers, clinicians, public health specialists, policymakers, funding bodies, regulatory authorities, advocacy groups, and organisations working on maternal and newborn health to advance readiness for maternal Group B Streptococcus immunisation.
Who can apply
- The symposium is designed for researchers, public health professionals, clinicians, surveillance specialists, policymakers, funding bodies, regulatory authorities, advocacy groups, and organisations engaged in maternal and newborn health.
- Abstract presenters should follow the official abstract submission instructions and thematic guidance.
What it supports
- Maternal GBS vaccine readiness, routine GBS surveillance, improved disease-burden measurement, research priorities, evidence-based change, and collaboration across Europe and globally.
- The programme includes state-of-the-art plenary talks, scientific exchange, and discussion of strategies to reduce invasive GBS disease, stillbirths, and preterm births.
Fees, funding, or support
Registration is required. The official page lists early-bird fees of DKK 2,000 for high-income country participants, DKK 1,000 for LMIC participants and students, and DKK 650 for LMIC students until 30 June 2026.
Abstract submission deadline
Abstract submission deadline: May 25, 2026
How to apply
Submit abstracts through the official Aarhus University abstract submission page by 25 May 2026. Registration is open through the official symposium registration page.
Call details
The symposium will convene researchers, clinicians, public health specialists, policymakers, funding bodies, regulatory authorities, advocacy groups, and organisations working on maternal and newborn health to advance readiness for maternal Group B Streptococcus immunisation.
Aarhus University lists this opportunity for 2 to 4 September 2026, Radisson Blu Scandinavia Hotel, Aarhus, Denmark. Applicants should use the official call page to confirm final requirements before submitting.
The symposium is designed for researchers, public health professionals, clinicians, surveillance specialists, policymakers, funding bodies, regulatory authorities, advocacy groups, and organisations engaged in maternal and newborn health.
Abstract presenters should follow the official abstract submission instructions and thematic guidance.
Maternal GBS vaccine readiness, routine GBS surveillance, improved disease-burden measurement, research priorities, evidence-based change, and collaboration across Europe and globally.
The programme includes state-of-the-art plenary talks, scientific exchange, and discussion of strategies to reduce invasive GBS disease, stillbirths, and preterm births.
Registration is required. The official page lists early-bird fees of DKK 2,000 for high-income country participants, DKK 1,000 for LMIC participants and students, and DKK 650 for LMIC students until 30 June 2026.
Abstract submission deadline: Abstract submission deadline: May 25, 2026.
Confirm the exact deadline time, time zone, and submission route on the official call page.
Plan internal approvals, partner confirmations, budgets, letters, and portal submission before the final deadline.
Submit abstracts through the official Aarhus University abstract submission page by 25 May 2026. Registration is open through the official symposium registration page.
Before submitting, check required documents, eligible costs, attachments, page limits, institutional approvals, and whether the opportunity uses an expression of interest, full proposal, registration, or nomination stage.